Penile Implant — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

A penile implant (penile prosthesis) is a surgically implanted device placed within the erectile chambers (corpora cavernosa) of the penis to restore the ability to achieve and maintain a penile erection sufficient for sexual intercourse, in men with organic erectile dysfunction (ED) that has not responded to first- and second-line treatments. It is considered the third-line treatment option for ED, reserved for men who have failed oral phosphodiesterase type-5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil), intraurethral alprostadil (MUSE), and intracavernosal injection therapy (alprostadil, papaverine, phentolamine), or for whom these therapies are contraindicated.

Three main prosthesis designs are available. The three-piece inflatable penile prosthesis (IPP) — the gold standard — consists of paired intracorporal cylinders, a scrotal pump, and a fluid reservoir placed in the retropubic space. The patient activates erection by squeezing the scrotal pump, which transfers fluid from the reservoir into the cylinders; the reverse squeeze deflates the device. The two-piece inflatable prosthesis uses a rear-tip reservoir within the cylinders without a separate abdominal reservoir, providing a simpler mechanism suited for patients who have had prior pelvic surgery or radiotherapy. Malleable (semi-rigid) rod prostheses consist of paired flexible rods that maintain a permanent semi-rigid state, which can be manually positioned for intercourse and bent down for concealment; they offer the simplest mechanism with no moving parts.

The penile implant market has matured significantly over 50 years. Modern three-piece IPP devices from leading manufacturers (Boston Scientific AMS 700 series, Coloplast Titan) incorporate antibiotic-impregnated or hydrophilic-coated cylinders, lock-out valves preventing auto-inflation, and improved cylinder materials that achieve among the highest patient satisfaction rates of all urological surgical procedures.

Penile implant surgery is the appropriate treatment for men with irreversible organic erectile dysfunction where all conservative therapies have been exhausted or are contraindicated, and who desire reliable, spontaneous erections for sexual activity.

Primary indications: - Post-radical prostatectomy ED: Neurovascular bundle injury during prostatectomy is the most common indication. Men who have failed adequate trials of PDE5 inhibitors and injection therapy after 12–24 months of nerve recovery are excellent penile implant candidates with the highest satisfaction rates - Peyronie's disease with severe curvature and ED: Concurrent implantation with modelling or incision and grafting corrects curvature and restores rigidity simultaneously - Diabetes mellitus with vascular and neuropathic ED: Diabetic ED is commonly refractory to medications; penile implant provides reliable function - Penile venous insufficiency (venous leak): Cavernosal smooth muscle atrophy prevents veno-occlusion; implant is the only effective treatment - Spinal cord injury: Upper motor neuron injury patients may have reflexogenic erections but insufficient for intercourse; implant provides reliable erection independent of neural function - Priapism sequelae: Ischaemic priapism causes permanent cavernosal fibrosis, making PDE5 inhibitors ineffective; early implant placement (within 14 days) prevents severe fibrosis - Penile reconstruction: Post-phalloplasty after gender-affirming surgery or traumatic penile loss — malleable prosthesis is the standard

Prerequisites: Erectile dysfunction must be documented as organic and refractory to first- and second-line therapies. Patients must be fully informed about the permanent nature of the procedure — implantation causes irreversible corporal changes making natural erection recovery impossible after device removal. Psychological evaluation is recommended for patients with unrealistic expectations or body dysmorphic concerns. Uncontrolled diabetes (HbA1c above 8.5–9%) substantially increases infection risk and should be optimised before surgery.

Penile implant surgery is performed in an operating room under general or spinal anaesthesia, with meticulous attention to sterility to minimise infection risk — the most feared complication.

Pre-operative preparation: Prophylactic broad-spectrum antibiotics (typically gentamicin plus vancomycin, or cephalosporins) are administered 30–60 minutes before incision and continued for 24 hours post-operatively. Surgical site preparation includes clipping (not shaving) of the genital area to reduce skin flora, chlorhexidine-alcohol skin preparation, and sterile draping. A no-touch surgical technique — in which the implant components are never handled with gloved fingers after sterile preparation — minimises bacterial contamination during device implantation.

Surgical access: A penoscrotal incision (between the base of the penis and the scrotum) or infrapubic incision (just above the base of the penis) provides access to the corpora cavernosa. Penoscrotal access is preferred by most urologists as it allows optimal sizing of cylinders and easier scrotal pump placement.

Corporal dilation and cylinder insertion: The corpora cavernosa are opened with a small incision. Sequential metallic dilators of increasing size are used to dilate the corporal bodies from the glans to the crura. Corporal sizing determines the cylinder length (typically 16–24 cm total length with rear-tip extenders). Paired inflatable cylinders are inserted with their tips positioned at the glans and their proximal ends anchored in the crural fixation points using sutures.

Reservoir and pump placement (three-piece IPP): The scrotal pump is placed in the most dependent portion of the scrotum, secured in a sub-dartos pouch to prevent migration. The fluid reservoir is placed in the Space of Retzius (retropubic prevesical space) via blunt dissection through the external inguinal ring — or, in patients with prior pelvic surgery or radiotherapy who may have obliterated this space, ectopically behind the external oblique fascia or the transversalis fascia.

System testing and wound closure: The prosthesis components are connected with Tubing, the device is cycled through several inflation-deflation cycles to verify function, and the tubing is connected and secured with connector clips. The device is left in the deflated position. The wound is closed in layers with absorbable sutures and a compression dressing applied to reduce haematoma.

The penile prosthesis achieves among the highest satisfaction rates of all urological procedures, reflecting its reliable, predictable restoration of erection function for men who have exhausted all other ED treatment options.

Patient and partner satisfaction: Inflatable penile prosthesis satisfaction rates exceed 90–95% for patients and 85–90% for partners in prospective multi-centre studies at 5 years. These satisfaction rates are higher than for any other ED treatment modality. The superior satisfaction compared with intraurethral or intracavernosal therapies reflects the spontaneity and predictability of inflatable device erection versus the effort and discomfort of injections or suppositories.

Device survival: Modern three-piece inflatable prosthesis mechanical reliability — freedom from device malfunction requiring surgical revision — is 90–95% at 5 years and 80–85% at 10 years. The most common mechanical failure is fluid connector tubing separation or cylinder aneurysm development, both of which are managed with device revision surgery.

Sexual function outcomes: All patients achieve penile rigidity sufficient for vaginal penetration after device activation. Penile length preservation is dependent on corporal dilation during implantation — vigorous dilation maintains length, while fibrosis (particularly in post-prostatectomy or post-priapism cases) may limit achievable cylinder length and result in perceived penile shortening compared with the pre-disease state.

Quality of life: Prospective quality-of-life studies demonstrate significant improvements in sexual self-confidence, relationship satisfaction, and psychological wellbeing after penile prosthesis implantation in appropriately counselled patients.

While penile implant surgery achieves high satisfaction, the complication profile is important and must be thoroughly discussed during pre-operative counselling.

Infection: The most serious complication, occurring in 1–3% of primary implants in non-diabetic patients and 3–5% in diabetic patients. Infection typically presents within 1–3 months with fever, scrotal pain, erythema, and purulent discharge. Device salvage with immediate explantation, antibiotic irrigation, and re-implantation (Mulcahy salvage technique) can recover the situation in 80–90% of cases when performed within 48 hours of infection recognition. In most cases, the infected device must be removed, the space maintained with temporary catheters or spacers, and re-implantation planned after 3–6 months of antibiotic therapy. Antibiotic-impregnated (InhibiZone) and hydrophilic-coated (Titan OTR) cylinders have reduced infection rates to under 1% in prospective clinical series.

Mechanical failure: Connector tubing separation, cylinder aneurysm, S-shaped deformity, auto-inflation, or reservoir herniation occur in 5–10% of patients over 10 years. Most require surgical device revision under general anaesthesia.

Urethral injury: Accidental urethral perforation during corporotomy or dilation occurs in under 1% and requires immediate repair, temporary urethral catheterisation, and delayed device implantation after healing.

Penile shortening: Penile length is often perceived to be shorter after implantation compared with pre-disease erect length, due to cavernosal fibrosis and scarring that limits dilation. This is a common complaint in post-prostatectomy and post-priapism patients. Penile traction therapy or vacuum erection device use in the months before planned surgery may optimise achievable length.

Erosion: Cylinder erosion through the glans (from too-long cylinders) or pump erosion through the scrotal skin (from too-superficial placement) occurs in under 1% and requires device removal and revision.

Recovery from penile implant surgery is guided by the surgeon's protocol, device manufacturer recommendations, and the patient's individual healing.

Day of surgery and discharge: Most patients are discharged the same day or the morning after surgery. A urinary catheter is placed intraoperatively and typically removed before discharge or the next morning. Scrotal and penile swelling, bruising, and discomfort are normal and peak on days 2–5. Pain is well-managed with oral paracetamol and ibuprofen; opioids are prescribed for the first 3–5 days if needed.

Weeks 1–2: A penile compression dressing and scrotal support underwear reduce oedema. Activity is restricted to walking and light daily activities. Lifting more than 5 kg, vigorous activity, and driving are avoided for 1–2 weeks. Ice packs applied to the perineum and scrotum (20 minutes on, 20 minutes off) reduce swelling in the first 48 hours.

Device conditioning (weeks 4–6): At 4–6 weeks, the surgeon demonstrates device inflation and deflation at the clinic visit. Daily device cycling — inflating fully for 5–10 minutes and deflating — conditions the cylinders, stretches the scar tissue, and optimises penile length and rigidity. Patients are instructed in independent device cycling before the clinical activation visit.

Sexual activity: Sexual activity is typically permitted at 6 weeks after the first follow-up visit confirms satisfactory wound healing, device position, and cycling function. Partners should be counselled that the implant provides rigidity — not sensation or ejaculation — and that these functions remain dependent on intact neurological pathways unaffected by the device.

Long-term device care: The device requires no routine maintenance. Annual urology review is recommended to assess device function and patient satisfaction. Patients are given an implant identification card listing the device model and implant date, which must be presented before any urological procedures or MRI examinations.